Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
No Data Found
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-2.40%
EBIT Growth (5y)
22.02%
EBIT to Interest (avg)
-2.30
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.43
Sales to Capital Employed (avg)
1.25
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.91%
ROE (avg)
6.47%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
Industry P/E
Price to Book Value
NA
EV to EBIT
3.33
EV to EBITDA
2.20
EV to Capital Employed
0.27
EV to Sales
0.17
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
8.20%
ROE (Latest)
6.75%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend15What is working for the Company
NET SALES(9M)
At VND 182,713.53 MM has Grown at 32.04%
ROCE(HY)
Highest at 7.18%
INVENTORY TURNOVER RATIO(HY)
Highest at 3.6%
DEBTORS TURNOVER RATIO(HY)
Highest at 7.25%
RAW MATERIAL COST(Y)
Fallen by -4.93% (YoY
NET PROFIT(9M)
Higher at VND 5,259.98 MM
DEBT-EQUITY RATIO
(HY)
Lowest at 37.62 %
-9What is not working for the Company
NET SALES(Q)
At VND 50,026.33 MM has Fallen at -14.32%
PRE-TAX PROFIT(Q)
At VND 1,225 MM has Fallen at -36.1%
NET PROFIT(Q)
At VND 1,225 MM has Fallen at -36.1%
OPERATING PROFIT(Q)
Lowest at VND 2,327.38 MM
OPERATING PROFIT MARGIN(Q)
Lowest at 4.65 %
Here's what is working for Lamdong Pharmaceutical JSC
Inventory Turnover Ratio
Highest at 3.6% and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Debtors Turnover Ratio
Highest at 7.25% and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Debt-Equity Ratio
Lowest at 37.62 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Raw Material Cost
Fallen by -4.93% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Lamdong Pharmaceutical JSC
Net Sales
At VND 50,026.33 MM has Fallen at -14.32%
over average net sales of the previous four periods of VND 58,384.75 MMMOJO Watch
Near term sales trend is extremely negative
Net Sales (VND MM)
Pre-Tax Profit
At VND 1,225 MM has Fallen at -36.1%
over average net sales of the previous four periods of VND 1,916.94 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (VND MM)
Net Profit
At VND 1,225 MM has Fallen at -36.1%
over average net sales of the previous four periods of VND 1,916.94 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (VND MM)
Operating Profit
Lowest at VND 2,327.38 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (VND MM)
Operating Profit Margin
Lowest at 4.65 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
